New NEJM Study Finds Pfizer’s Paxlovid Does ‘Little or Nothing’ for COVID-19

By News on the Net —— Bio and Archives April 8, 2024

Comments | Print This | Subscribe | Email Us

New NEJM Study Finds Pfizer’s Paxlovid Does ‘Little or Nothing’ for COVID-19

“Kind of shocking a drug that costs $1,300…is showing in a randomized controlled trial to not really relieve COVID symptoms. That’s a lot of money for something that provenly doesn’t work it seems.”

???? New NEJM Study Finds Pfizer’s Paxlovid Does ‘Little or Nothing’ for COVID-19

“Kind of shocking a drug that costs $1,300…is showing in a randomized controlled trial to not really relieve COVID symptoms. That’s a lot of money for something that provenly doesn’t work it… pic.twitter.com/NWZV1ErSYu

— Chief Nerd (@TheChiefNerd)April 7, 2024